₹ 14.25
-0.75 (-5.00%)
BSE
N
Norris Medicines
₹ 14.25
BSE
NORRIS Financials Summary
Norris Medicines revenue decreased 35.71% quarter-on-quarter to ₹1 Cr in Jun 2026, while net profit swung to a loss of ₹0 Cr from a profit of ₹0 Cr in the previous quarter. Compared to the same quarter last year, revenue is down 40.00% and net loss widened to ₹0 Cr from ₹0 Cr a year ago. EPS for the quarter stood at -₹0.40, decreased from ₹0.05 in the previous quarter and down from -₹0.31 a year ago.
Norris Medicines Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of NORRIS Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
NORRIS Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






